On the first day of a seven-week trial, the applicant in a class action against Monsanto has taken aim at the agrochemical giant’s “same old approach” to undermining decades of evidence it says demonstrates the cancer-causing properties of popular weed killer Roundup.
Agrochemical giant Monsanto is digging in for a fight in a class action over its alleged carcinogenic weed killer, Roundup, having refused to budge in mediation despite a $16 billion settlement in the US.
The judge overseeing a class action against Monsanto over its weed killer has rejected the agrochemical giant’s application to amend the common questions to be decided at a liability trial to account for its alternative defence.
A busy judge has pushed the parties in a class action against agrochemical giant Monsanto to split the trial to focus first on the question of whether the company’s Roundup weed killer causes cancer so that he can avoid writing a judgment of “hundreds and hundreds” of pages.
An upcoming three-month trial in a class action against agrochemical giant Monsanto has been vacated after the applicant’s key expert withdrew from the case.